…if Roche wasn't involved and a smaller company was in control of the drug, they would have gone into phase 2 with the wrong dose and it would have been a failed drug.
You’ve hit on the crux of this series of articles from an investment standpoint. I wonder if the NYT author was able to make this connection.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.